UK MHRA proposes fee hike for medtech clinical investigation notifications
This article was originally published in SRA
Executive Summary
The fees for medtech clinical investigation notifications in the UK could rise from 1 April 2013 if a proposal by the Medicines and Healthcare products Regulatory Agency is finalised1.